Literature DB >> 11502527

Drug interactions with clinafloxacin.

E J Randinitis1, C W Alvey, J R Koup, G Rausch, R Abel, N J Bron, N J Hounslow, A B Vassos, A J Sedman.   

Abstract

Many fluoroquinolone antibiotics are inhibitors of cytochrome P450 enzyme systems and may produce potentially important drug interactions when administered with other drugs. Studies were conducted to determine the effect of clinafloxacin on the pharmacokinetics of theophylline, caffeine, warfarin, and phenytoin, as well as the effect of phenytoin on the pharmacokinetics of clinafloxacin. Concomitant administration of 200 or 400 mg of clinafloxacin reduces mean theophylline clearance by approximately 50 and 70%, respectively, and reduces mean caffeine clearance by 84%. (R)-Warfarin concentrations in plasma during clinafloxacin administration are 32% higher and (S)-warfarin concentrations do not change during clinafloxacin treatment. An observed late pharmacodynamic effect was most likely due to gut flora changes. Phenytoin has no effect on clinafloxacin pharmacokinetics, while phenytoin clearance is 15% lower during clinafloxacin administration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11502527      PMCID: PMC90690          DOI: 10.1128/AAC.45.9.2543-2552.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  38 in total

Review 1.  Potential interactions of the extended-spectrum fluoroquinolones with the CNS.

Authors:  H Lode
Journal:  Drug Saf       Date:  1999-08       Impact factor: 5.606

Review 2.  Inhibition of drug metabolism by quinolone antibiotics.

Authors:  D J Edwards; S K Bowles; C K Svensson; M J Rybak
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

3.  Pharmacokinetics of clinafloxacin after single and multiple doses.

Authors:  E J Randinitis; J I Brodfuehrer; I Eiseman; A B Vassos
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

4.  Clinafloxacin pharmacokinetics in subjects with various degrees of renal function.

Authors:  E J Randinitis; J R Koup; G Rausch; R Abel; N J Bron; N J Hounslow; A B Vassos; A J Sedman
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

5.  Ecological disturbances in intestinal microflora caused by clinafloxacin, an extended-spectrum quinolone.

Authors:  H Oh; C E Nord; L Barkholt; M Hedberg; C Edlund
Journal:  Infection       Date:  2000-09       Impact factor: 3.553

Review 6.  Interactions between anticonvulsants and other commonly prescribed drugs.

Authors:  H Kutt
Journal:  Epilepsia       Date:  1984       Impact factor: 5.864

7.  Paracetamol as a test drug to determine glucuronide formation in man. Effects of inducers and of smoking.

Authors:  K W Bock; J Wiltfang; R Blume; D Ullrich; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

8.  Enoxacin-warfarin interaction: pharmacokinetic and stereochemical aspects.

Authors:  S Toon; K J Hopkins; F M Garstang; L Aarons; A Sedman; M Rowland
Journal:  Clin Pharmacol Ther       Date:  1987-07       Impact factor: 6.875

Review 9.  Antibiotic-associated hypoprothrombinaemia.

Authors:  J J Lipsky
Journal:  J Antimicrob Chemother       Date:  1988-03       Impact factor: 5.790

10.  Possible interaction between ciprofloxacin and warfarin.

Authors:  A K Kamada
Journal:  DICP       Date:  1990-01
View more
  3 in total

1.  Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19.

Authors:  Alice Ban Ke; Srikanth C Nallani; Ping Zhao; Amin Rostami-Hodjegan; Jashvant D Unadkat
Journal:  Br J Clin Pharmacol       Date:  2014-03       Impact factor: 4.335

2.  Interactions Between Antiepileptic and Antibiotic Drugs: A Systematic Review and Meta-Analysis with Dosing Implications.

Authors:  Carla Carnovale; Marco Pozzi; Faizan Mazhar; Giulia Mosini; Marta Gentili; Gabriëlla G A M Peeters; Emilio Clementi; Sonia Radice
Journal:  Clin Pharmacokinet       Date:  2019-07       Impact factor: 6.447

3.  Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta-lactams.

Authors:  Mathieu S Bolhuis; Prashant N Panday; Arianna D Pranger; Jos G W Kosterink; Jan-Willem C Alffenaar
Journal:  Pharmaceutics       Date:  2011-11-18       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.